PT-141 (Bremelanotide) is a synthetic peptide widely utilized in laboratory research for the study of melanocortin receptor activity, neuropeptide signaling pathways, and central nervous system communication mechanisms. It is commonly investigated for its interaction with melanocortin receptors and its influence on cellular processes associated with neurotransmitter signaling, receptor binding dynamics, and neuroendocrine pathway modulation within controlled experimental models.
In research environments, PT-141 is used to explore pathways related to signal transduction, neuronal communication, and coordinated receptor-mediated responses at the molecular level. Its receptor-specific activity makes it valuable for analyzing downstream signaling cascades, peptide-receptor interactions, and neuroendocrine regulatory systems. This compound is also of interest in broader studies focused on central signaling pathways, receptor activation efficiency, and cellular response modulation across repeatable laboratory protocols.
Reconstitution (For Research Reference Only):
Add 2mL of bacteriostatic water to achieve a concentration of 10mg/mL. At this concentration, each 0.1mL (10 units on a standard insulin syringe) corresponds to 1mg of compound. This information is provided strictly for laboratory research standardization and measurement purposes.
This product is supplied in lyophilized (freeze-dried) form within a sealed vial to ensure stability and precision in handling. It is intended exclusively for laboratory research, analytical, and educational purposes and is not approved for—and must not be used for—human or animal consumption.



